DSG Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:DSG Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10927
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DSG Inc (DSG) is a provider of eClinical software solutions. The company offers software products such as eCaseLink EDC, eClinDirect CTMS, eCaseLink.Me ePRO, DSG Drug Safety, eCaseLink IRT, DSG Designer, CaseXport, CaseView Imaging, and others. Its services include data management, technology transfer, technical support, project management, clinical trials training, document management, data integration, and secure web hosting services. DSG caters its solutions for pharmaceutical, medical device and life sciences industries. The company operates through its offices located in Malvern and Oaks, the US; Noida and Bangalore, India and Taipei, Taiwan. DSG is headquartered in Malvern, Pennsylvania, the US.

DSG Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
DSG Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DSG Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DSG Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DSG Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
DSG Inc, Medical Devices Deals, 2012 to YTD 2018 9
DSG Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
DSG Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
DSG Enters into Licensing Agreement with Integrium 11
Orbus Therapeutics Enters into Agreement with DSG 12
Licensing Agreements 13
Opko Health Enters into Licensing Agreement with DSG 13
DSG Inc – Key Competitors 14
DSG Inc – Key Employees 15
DSG Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Other Significant Developments 17
Jun 25, 2018: Enhancing the EDC Experience with eCaseLink 10 from DSG 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
DSG Inc, Pharmaceuticals & Healthcare, Key Facts 2
DSG Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DSG Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DSG Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DSG Inc, Deals By Therapy Area, 2012 to YTD 2018 8
DSG Inc, Medical Devices Deals, 2012 to YTD 2018 9
DSG Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
DSG Enters into Licensing Agreement with Integrium 11
Orbus Therapeutics Enters into Agreement with DSG 12
Opko Health Enters into Licensing Agreement with DSG 13
DSG Inc, Key Competitors 14
DSG Inc, Key Employees 15
DSG Inc, Other Locations 16
DSG Inc, Subsidiaries 16

List of Figures
DSG Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
DSG Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
DSG Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
DSG Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DSG Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
DSG Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DSG Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
DSG Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[DSG Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ImmunoClin Corp (IMCL):企業財務及び戦略的SWOT分析
    Summary ImmunoClin Corp (ImmunoClin) formerly Pharma Investing News, Inc focuses on the immunology research and development to offer services to pharmaceutical, biotechnology and food industries. The company’s product portfolio comprises Multi-Variant Atherosclerosis Risk Assessment (MARA), Genetic …
  • TCFC Finance Limited (532284):企業の財務及び戦略的SWOT分析
    Summary TCFC Finance Limited (TCFC Finance) is a non-banking finance company with core activities in the business of finance and investments and trading in equity shares, mutual funds and securities. The company is an investment company that operates its business through investments in equity, debt, …
  • Shenzhen Energy Group Co., Ltd. (000027):企業概要、財務及び戦略的SWOT分析
    Summary Shenzhen Energy Group Co., Ltd. (Shenzhen Energy) is an electric utility. The company develops, produces, purchases and markets conventional energies and new energies such as electricity and natural gas. It invests in energy related raw material, ports, dock and storage industry. Shenzhen En …
  • San Juan Basin Royalty Trust (SJT):企業財務及び戦略的SWOT分析
    Summary San Juan Basin Royalty Trust (SJT) is a trust that has overriding royalty interest divided out of Southland Royalty's oil and gas leasehold and royalty interest in the San Juan Basin of northwestern New Mexico. The trust’s underlying properties include working interests, overriding royalty i …
  • IMG Worldwide, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' IMG Worldwide, Inc. Mergers and …
  • Greggs Plc:企業の戦略・SWOT・財務情報
    Greggs Plc - Strategy, SWOT and Corporate Finance Report Summary Greggs Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Trafigura Group Pte. Ltd.:企業の戦略的SWOT分析
    Trafigura Group Pte. Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Allozyne, Inc.(製薬・医療分野):企業M&A動向
    Summary Allozyne, Inc. (Allozyne) is a biopharmaceutical company. The company develops biological therapeutics to treat cancer, autoimmune and inflammatory diseases. Its products include AZ01, AZ17 and AZ05. Allozyne’s AZ01 is a long acting form of interferon beta used in the treatment of relapsing- …
  • Population Diagnostics Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Population Diagnostics Inc. (Population Diagnostics) is a biotechnology company. It carries out the research, development and discovery of platform technology for validation of causative genetic biomarkers. The company by utilizing its causative biomarkers in human genetics develops and mark …
  • University of California San Francisco:企業のM&A・提携動向(医療機器分野)
    Summary University of California San Francisco (UCSF), a subsidiary of University of California, is an education and research institution. The university provides resourcing and training programs; education, research and patient care services. It provides professional educational courses in dentistr …
  • Nexira:戦略・SWOT・企業財務分析
    Nexira - Strategy, SWOT and Corporate Finance Report Summary Nexira - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Cavitation Technologies, Inc. (CVAT):企業概要、財務及び戦略的SWOT分析
    Summary Cavitation Technologies, Inc. (Cavitation) is an energy service company. The company develops and offers processing technologies for use in edible oil refining, algal oil extraction and renewable fuel production, alcoholic beverage enhancement, water treatment and expeditious petroleum upgra …
  • SolarEdge Technologies Inc (SEDG):電力:M&Aディール及び事業提携情報
    Summary SolarEdge Technologies Inc (SolarEdge) is a provider of intelligent inverter solutions for the photovoltaic (PV) industry. The company provides module-level power electronics for solar power harvesting and monitoring. Its system consists of inverters, power optimizers, storage solutions, and …
  • Unichem Laboratories Ltd. (UNICHEMLAB):企業概要、財務及び戦略的SWOT分析
    Summary Unichem Laboratories Ltd. (Unichem) is a pharmaceutical company. It undertakes manufacturing of active pharmaceutical ingredients (APIs) and formulations. The company manufactures formulations that are used in therapeutic areas such as gastroenterology, anti-invectives, anti-bacterial, diabe …
  • Etam Developpement SCA:企業の戦略・SWOT・財務分析
    SummaryEtam Developpement SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Straumann Holding AG (STMN):企業のM&A・提携動向(医療機器分野)
    Summary Straumann Holding AG (Straumann) develops dental implants and devices. Straumann’s product portfolio includes dental implants, active surfaces, prosthetic components, digital solutions such as intra-oral scanning, and CADCAM, bone substitutes, and regenerative membranes. The company categori …
  • curasan AG (CUR):製薬・医療:M&Aディール及び事業提携情報
    Summary curasan AG (curasan) develops, manufactures and commercializes medical devices in the field of regenerative medicine. The company offers a wide range of synthetic bone substitutes, dental and bone regeneration material products. It offers these products to orthopedic and spinal surgeons, ora …
  • CDEX, Inc. (CDEX):企業概要、財務及び戦略的SWOT分析
    Summary CDEX, Inc. (CDEX) is a healthcare service provider. The company develops, manufactures and distributes products for the healthcare and security markets. It develops advanced validation and chemical detection devices. CDEX offers products such as photoemission spectroscopy technology. The com …
  • Inter RAO UES (IRAO):企業のM&A・提携動向(エネルギー分野)
    Summary Inter RAO UES (Inter RAO) is a diversified energy holding group. It is one of the leading energy export and import operators in Russia. The group is engaged in electric power and heat generation, international power trading, retail electricity sales, management of distribution grids outside …
  • Thermalin Diabetes LLC:企業のM&A・提携動向(医療分野)
    Summary Thermalin Diabetes LLC (Thermalin) is a biotechnology company that manufactures and develops insulin analogs. The company is developing ultra-concentrated insulin analog for the treatment of individuals with high insulin resistance and for use in miniature insulin pumps. It is developing bot …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆